相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy
Elion Hoxha et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
A Proposal for a Serology-Based Approach to Membranous Nephropathy
An S. De Vriese et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
Karine Dahan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Treatment of membranous nephropathy: time for a paradigm shift
Piero Ruggenenti et al.
NATURE REVIEWS NEPHROLOGY (2017)
Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis
I. Fleury et al.
ANNALS OF ONCOLOGY (2016)
Glomerular diseases and cancer: evaluation of underlying malignancy
Antonello Pani et al.
JOURNAL OF NEPHROLOGY (2016)
PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians
Raja Ramachandran et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
Niels W. C. J. van de Donk et al.
IMMUNOLOGICAL REVIEWS (2016)
Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms
Corrado Murtas et al.
JOURNAL OF NEPHROLOGY (2016)
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
Duncan Porter et al.
LANCET (2016)
Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data
Mark D. Danese et al.
MEDICAL CARE (2016)
A Mechanism for Cancer-Associated Membranous Nephropathy
Elion Hoxha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Renal Phospholipase A(2) Receptor in Hepatitis B Virus-Associated Membranous Nephropathy
Qionghong Xie et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
K. Rajender Reddy et al.
GASTROENTEROLOGY (2015)
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
Piero Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
Pierre Ronco et al.
LANCET (2015)
Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy
Thomas Stehle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy
Elion Hoxha et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus
Jara Caro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study
Jorge Rojas-Rivera et al.
CLINICAL KIDNEY JOURNAL (2015)
M-type Phospholipase A2 Receptor Autoantibodies and Renal Function in Patients with Primary Membranous Nephropathy
Elion Hoxha et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy
Anneke P. Bech et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy
Choli Hartono et al.
JOURNAL OF NEPHROLOGY (2014)
A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (HP ActharA® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy
Michelle A. Hladunewich et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Nicola M. Tomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
Yu Du et al.
PLOS ONE (2014)
PLA2R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System
Elion Hoxha et al.
PLOS ONE (2014)
Anti-Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
Sjoerd A. M. E. G. Timmermans et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Standard immunosuppressive therapy of immune-mediated glomerular diseases
Antonello Pani
AUTOIMMUNITY REVIEWS (2013)
Rituximab for the second- and third-line therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy
Martin Busch et al.
CLINICAL NEPHROLOGY (2013)
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
Preetesh Jain et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies
Christopher P. Larsen et al.
MODERN PATHOLOGY (2013)
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
Durga Kanigicherla et al.
KIDNEY INTERNATIONAL (2013)
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial
Andrew Howman et al.
LANCET (2013)
Treatment of idiopathic membranous nephropathy
Julia M. Hofstra et al.
NATURE REVIEWS NEPHROLOGY (2013)
Belimumab for Systemic Lupus Erythematosus
Bevra Hannahs Hahn
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Treatment of Resistant Glomerular Diseases with Adrenocorticotropic Hormone Gel: A Prospective Trial
Andrew S. Bomback et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Venous Thromboembolism in Patients with Membranous Nephropathy
Sophia Lionaki et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Prognostic Value of Risk Score and Urinary Markers in Idiopathic Membranous Nephropathy
Jan A. J. G. van den Brand et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Rituximab: emerging treatment strategies of immune-mediated glomerular disease
Andrea G. Kattah et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
Novel CD20 monoclonal antibodies for lymphoma therapy
Shundong Cang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Rituximab in Idiopathic Membranous Nephropathy
Piero Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
Julia M. Hofstra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
OPINION The renaissance of corticotropin therapy in proteinuric nephropathies
Rujun Gong
NATURE REVIEWS NEPHROLOGY (2012)
Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy
Julia M. Hofstra et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma
Corrado Tarella et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy
Shigeru Kusumoto et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy
Weisong Qin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
Maurizio Benucci et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
Fernando C. Fervenza et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Melanocortin 1 Receptor Agonists Reduce Proteinuria
Annika Lindskog et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy
Natalia Polanco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.
Laurence H. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mycophenolate mofetil monotherapy in membranous nephropathy: A 1-year randomized controlled trial
Bertrand Dussol et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Rituximab treatment of idiopathic membranous nephropathy
F. C. Fervenza et al.
KIDNEY INTERNATIONAL (2008)
Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy
Paolo Cravedi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mycophenolate mofetil in idiopathic membranous nephropathy: A clinical trial with comparison to a historic control group treated with cyclophosphamide
Amanda J. Branten et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Progressive multifocal leukoencephalopathy in rheumatic diseases - Evolving clinical and pathologic patterns of disease
Leonard H. Calabrese et al.
ARTHRITIS AND RHEUMATISM (2007)
A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy
Vivekanand Jha et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Tacrolimus monotherapy in membranous nephropathy:: A randomized controlled trial
M. Praga et al.
KIDNEY INTERNATIONAL (2007)
Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome
Efstathios Alexopoulos et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy
C Ponticelli et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy
PWG du Buf-Vereijken et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Activation of cytokine production by secreted phospholipase A(2) in human lung macrophages expressing the M-type receptor
F Granata et al.
JOURNAL OF IMMUNOLOGY (2005)
The Italian experience of the national registry of renal biopsies
L Gesualdo et al.
KIDNEY INTERNATIONAL (2004)
Rituximab in idiopathic membranous nephropathy: A one year prospective study
P Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Antenatal membranous glomerulonephritis with vascular injury induced by anti-neutral endopeptidase antibodies: Toward new concepts in the pathogenesis of glomerular diseases
H Debiec et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Rituximab for idiopathic membranous nephropathy
G Remuzzi et al.
LANCET (2002)
Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy
A Torres et al.
KIDNEY INTERNATIONAL (2002)
Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
DC Cattran et al.
KIDNEY INTERNATIONAL (2001)
Use of mycophenolate mofetil in resistant membranous nephropathy
G Miller et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
